Skip to search formSkip to main contentSkip to account menu

forphenicine

Known as: 4-formyl-3-hydroxyphenylglycine, Benzeneacetic acid, alpha-amino-4-formyl-3-hydroxy-, forfenicin 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Glycine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
High-performance liquid chromatographic determination of forphenicine in mouse serum and muscle by pre-column fluorescence derivatization using 1,2-diamino-4,5-ethylenedioxybenzene as fluorogenic…
1985
1985
Immunopotentiation with forphenicinol: increased resistance to Pseudomonas septicaemia in mice.
UMEZAWA et al. found that forphenicine, isolated from culture filtrates of Actinomycetes fulvoviridis var. acarbodicus is a… 
1985
1985
Changes in the immunological parameters after a single dose of forphenicinol, a new small molecular immunomodifier.
Forphenicinol [L-2-(3-hydroxy-4-hydroxymethyl-phenyl) glycine, M.W. 197.19] is a derivative of forphenicine, an inhibitor of… 
1985
1985
Low molecular weight immunomodifiers produced by microorganisms.
Umezawa initiated the study of low molecular weight enzyme inhibitors produced by microorganisms and discovered more than 50… 
1985
1985
Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Forphenicinol (FPL) is a low molecular immunomodifier derived from forphenicine, a microbial product found by Umezawa and co… 
Review
1984
Review
1984
Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effort.
The screening for low-molecular-weight enzyme inhibitors produced by microorganisms was initiated in 1966, and by 1972 inhibitors… 
1984
1984
Similar effects of various low-molecular-weight enzyme inhibitors on enzyme networks in dystrophic mice.
We compared the therapeutic effects of various low-molecular-weight enzyme inhibitors on dystrophic mice. Leupeptin, bestatin… 
Review
1983
Review
1983
The Leeuwenhoek Lecture, 1982 - Studies of microbial products in rising to the challenge of curing cancer
  • H. Umezawa
  • Proceedings of the Royal Society of London…
  • 1983
  • Corpus ID: 5659729
The author’s studies, with his collaborators, on antitumour antibiotics, low molecular mass immunity-enhancing compounds by… 
1983
1983
[Phase I study of forphenicinol, a new biological response modifier].
Forphenicinol, [L-(4-hydroxymethyl-3-hydroxyphenyl) glycine], a new biological response modifier, is a derivative of forphenicine… 
Review
1980
Review
1980
Screening of small molecular microbial products modulating immune responses and bestatin.
  • H. Umezawa
  • Recent results in cancer research. Fortschritte…
  • 1980
  • Corpus ID: 36397571
Microorganisms are the treasury of organic compounds which have various structures and various biologic and medicinal activities… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)